Table 1 Baseline demographic and clinical characteristics
| Â | NO-CHOICE (RANDOMIZATION) | Â | Â | CHOICE | Â | TOTAL | |
|---|---|---|---|---|---|---|---|
| Â | PE | SER | Subtotal | PE | SER | Subtotal | Â |
Number of Patients (%) | 55 | 48 | 103 | 61 | 36 | 97 | 200 |
Age in years, mean (SD) | 36.2 (11.4) | 38.9 (11.3) | 37.5 (11.4) | 37.1 (11.3) | 38.3 (11.4) | 37.5 (11.3) | 37.5 (11.3) |
Gender (%) | |||||||
   Female | 78.2% | 79.2% | 78.6% | 75.4% | 69.4% | 73.2% | 76.0% |
   Male | 21.8% | 20.8% | 21.4% | 24.6% | 30.6% | 26.8% | 24.0% |
Education (College Educated) (%) | 38.2% | 23.0% | 31.1% | 42.6% | 22.2% | 35.1% | 33.0% |
PTSD Severity (PSS-I), mean (SD) | 29.7 (7.1) | 29.6 (6.3) | 29.7 (6.7) | 29.1 (6.8) | 30.0 (6.7) | 29.5 (6.7) | 29.6 (6.7) |
   Re-experiencing, mean (SD) | 7.8 (2.7) | 7.5 (3.0) | 7.7 (2.9) | 7.3 (2.7) | 7.5 (2.8) | 7.4 (2.7) | 7.5 (2.8) |
   Avoidance, mean (SD) | 12.3 (3.8) | 11.9 (3.4) | 12.1 (3.6) | 12.2 (3.1) | 12.4 (3.1) | 12.3 (3.1) | 12.2 (3.3) |
   Hyperarousal, mean (SD) | 9.6 (3.3) | 10.2 (2.5) | 9.9 (2.9) | 9.6 (2.9) | 10.1 (3.1) | 9.8 (3.0) | 9.8 (3.0) |
CGI-S, mean (SD) | 4.6 (1.0) | 4.5 (0.9) | 4.6 (1.0) | 4.6 (1.1) | 4.4 (0.9) | 4.5 (1.0) | 4.6 (1.0) |
EQ-5D, mean (SD) | 0.67 (0.18) | 0.60 (0.21) | 0.61 (0.20) | 0.65 (0.17) | 0.56 (0.19) | 0.62 (0.18) | 0.63 (0.19) |
QWB-SA, mean (SD) | 0.58 (0.11) | 0.57 (0.10) | 0.57 (0.11) | 0.56 (0.10) | 0.59 (0.11) | 0.57 (0.10) | 0.57 (0.11) |